Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation
Open Access
- 27 February 2006
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 37 (8) , 799-800
- https://doi.org/10.1038/sj.bmt.1705330
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacogenetics of folate-related drug targets in cancer treatmentPharmacogenomics, 2005
- Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemiaBlood, 2005
- Methylenetetrahydrofolate Reductase Genotype Affects Risk of Relapse after Hematopoietic Cell Transplantation for Chronic Myelogenous LeukemiaClinical Cancer Research, 2004
- A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levelsPharmacogenetics, 2004
- Cancer pharmacogenetics: polymorphisms, pathways and beyondNature Reviews Cancer, 2003
- Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexateAnnals of Oncology, 2002
- Effect of methylenetetrahydrofolate reductase 677C→T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patientsInternational Journal of Cancer, 2002
- Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphismBlood, 2001
- Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation development of an oral mucositis indexCancer, 1992